A recent study found that neutralization of CC2 can improve survival and remodel the tumor microenvironment in isocitrate dehydrogenase 1 (IDH1)-mutant cholangiocarcinoma (CCA), a highly aggressive sub-type of CCA [67]. Here, IDH1 is linked to cholangiocarcinoma.